Catalyst Wire Dossier Catalyst Wire Dossier

Raltegravir (Isentress)

raltegravir · Merck
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Raltegravir (Isentress), covering 2010-11-30 to 2021-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRAL [Phase 2]

See pricing